Nureca Limited

NSE:NURECA.NS

286.6 (INR) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Revenue 317.4264.63311.89202.69169.7223.74313.53212.31212.26277.88367.81255.28410.49480.77469.41,194.82318.4594.69919.28302.17329.6
Cost of Revenue 189.71165.31245.24164.55111.81158.79191.34144.21176.72167.13274.16170.81258.79292.53280.49494.43164.48328.34382.1696.78224.04
Gross Profit 127.6999.3266.6538.1457.8964.95122.1968.135.54110.7593.6584.47151.7188.24188.91700.39153.92266.35537.12205.39105.56
Gross Profit Ratio 0.4020.3750.2140.1880.3410.290.390.3210.1670.3990.2550.3310.370.3920.4020.5860.4830.4480.5840.680.32
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 0000-9.5900039.7300037.1700041.8818.5356.315.370
Selling & Marketing Expenses 000040.2700035.98000117.3800047.9447.9417.62.530
SG&A 42.7096.4268.3930.680069.2475.71092.70148.320105.66204.3189.8266.475159.8670.678.57
Other Expenses 120.91144.8600103.58113.41122.1900110.75084.470188.2426.0326.7-14.498.6056.641.640
Operating Expenses 120.91144.8696.4268.39103.58113.41122.1968.174.12110.7592.784.47151.7188.24131.69231.01153.92165.08176.0976.468.57
Operating Income 6.78-45.54-29.77-30.25-45.69-48.4691.54-34.86-37.37-15.17-55.27-63.36-25.5246.9757.22469.3853.95101.27368.19128.9735.65
Operating Income Ratio 0.021-0.172-0.095-0.149-0.269-0.2170.292-0.164-0.176-0.055-0.15-0.248-0.0620.0980.1220.3930.1690.170.4010.4270.108
Total Other Income Expenses Net 13.7313.0229.0256.44-19.0357.91-52.4225.5717.6417.8717.8810.366.4716.2319.8619.2-1.96-16.38-8.74-1.97-3.37
Income Before Tax 20.51-32.52-0.7526.19-64.729.4539.12-9.29-19.732.7-37.39-53-19.0563.277.08488.5851.9984.89359.4512732.28
Income Before Tax Ratio 0.065-0.123-0.0020.129-0.3810.0420.125-0.044-0.0930.01-0.102-0.208-0.0460.1310.1640.4090.1630.1430.3910.420.098
Income Tax Expense -4.16-4.514.079.57-23.267.810.18-2.22-4.43-0.31-8.47-11.71-5.1115.8622.74126.6213.0821.8692.1232.538.46
Net Income 24.67-28.01-4.8216.62-41.461.6528.94-7.07-15.33.01-28.92-41.29-14.0447.3454.34361.9638.9163.03267.3394.4723.82
Net Income Ratio 0.078-0.106-0.0150.082-0.2440.0070.092-0.033-0.0720.011-0.079-0.162-0.0340.0980.1160.3030.1220.1060.2910.3130.072
EPS 0-2.8-0.481.66-4.150.162.9-0.71-1.530.3-2.89-4.13-1.394.735.4336.24.568.5136.0913.53.4
EPS Diluted 0-2.8-0.481.66-4.150.162.9-0.71-1.530.3-2.89-4.13-1.394.735.4336.24.568.5136.0913.53.4
EBITDA 31.93-25.378.1434.25-56.9316.4645.84-2.3-13.089.8-30.18-45.58-10.2868.5681.44492.3255.2487.03368.53131.5335.843
EBITDA Ratio 0.101-0.0960.0260.169-0.3350.0740.146-0.011-0.0620.035-0.082-0.179-0.0250.1430.1730.4120.1730.1460.4010.4350.109